Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Syra Health Corp. Class A ( (SYRA) ).
On June 13, 2025, Syra Health Corp.’s Board of Directors terminated the employment agreement with CEO Deepika Vuppalanchi, initially established on April 5, 2021. Subsequently, on June 16, 2025, Priya Prasad, the company’s CFO and COO, was appointed as interim CEO, indicating a significant leadership transition within the company.
Spark’s Take on SYRA Stock
According to Spark, TipRanks’ AI Analyst, SYRA is a Neutral.
Syra Health’s overall stock score reflects strong revenue growth but is hindered by profitability challenges and negative cash flow. Technical indicators suggest bearish momentum, compounded by a negative valuation scenario. The earnings call offered some optimism with cost reductions and revenue growth, but concerns over delisting and funding uncertainties remain significant.
To see Spark’s full report on SYRA stock, click here.
More about Syra Health Corp. Class A
Average Trading Volume: 418,669
Technical Sentiment Signal: Sell
Current Market Cap: $1.05M
Learn more about SYRA stock on TipRanks’ Stock Analysis page.